TECLens Revenue and Competitors
Estimated Revenue & Valuation
- TECLens's estimated annual revenue is currently $2.9M per year.
- TECLens's estimated revenue per employee is $221,538
Employee Data
- TECLens has 13 Employees.
- TECLens grew their employee count by 225% last year.
TECLens's People
Name | Title | Email/Phone |
---|---|---|
1 | Executive Chairman and Co-founder | Reveal Email/Phone |
2 | Director Engineering | Reveal Email/Phone |
TECLens Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $0.2M | 5 | 25% | N/A | N/A |
#2 | $0.3M | 8 | -11% | N/A | N/A |
#3 | $2.9M | 13 | 225% | N/A | N/A |
#4 | $2.9M | 13 | 63% | N/A | N/A |
#5 | $3.5M | 74 | 155% | N/A | N/A |
#6 | $4.6M | 28 | 17% | $22M | N/A |
#7 | $8.3M | 32 | 10% | $12.9M | N/A |
#8 | $15M | 21 | 75% | N/A | N/A |
#9 | $3.5M | 36 | 0% | N/A | N/A |
#10 | $20.4M | 60 | 11% | N/A | N/A |
What Is TECLens?
TECLens is a clinical-stage ophthalmic medical device company, pioneering non-invasive personalized corneal cross-linking technology (qCXL™) for vision correction. Our innovative CXLens® system uses patterned ultraviolet (UV) light to gently reshape the cornea with continuous biomechanical control. qCXL is designed to be a comfortable, safe, and effective alternative to traditional refractive surgeries. TECLens’ breakthrough technology aims to set a new standard in precision, accessibility, and patient experience—redefining vision correction with innovation that improves quality of life.
keywords:N/AN/A
Total Funding
13
Number of Employees
$2.9M
Revenue (est)
225%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $2.1M | 13 | -13% | N/A |
#2 | $0.8M | 13 | N/A | N/A |
#3 | $1.2M | 14 | -7% | N/A |
#4 | $2.7M | 14 | -12% | N/A |
#5 | $1.3M | 15 | 36% | N/A |